GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Drd2 | multiple interactions | EXP | | 6480464 | CTD | olanzapine promotes the reaction [Dopamine binds to DRD2 protein] | PMID:15716360 | Drd2 | affects activity | ISO | DRD2 (Homo sapiens) | 6480464 | CTD | olanzapine affects the activity of DRD2 protein | PMID:10482380 | Drd2 | affects binding | ISO | Drd2 (Mus musculus) | 6480464 | CTD | olanzapine binds to DRD2 protein | PMID:24389121 | Drd2 | affects binding | ISO | DRD2 (Homo sapiens) | 6480464 | CTD | olanzapine binds to DRD2 protein | PMID:10831489 PMID:20361897 | Drd2 | decreases activity | ISO | DRD2 (Homo sapiens) | 6480464 | CTD | olanzapine results in decreased activity of DRD2 protein | PMID:11198054 | Drd2 | increases response to substance | ISO | DRD2 (Homo sapiens) | 6480464 | CTD | DRD2 gene SNP results in increased susceptibility to olanzapine; DRD2 intron SNP results in increased susceptibility to olanzapine | PMID:20375926 PMID:21187413 | |
Go Back to source page | Continue to Ontology report |